NLRP3 and Parkinson disease: Consequently, we postulate that Nurr1 may wield regulatory control over NLRP3 expression, thereby influencing the activation of the NLRP3 inflammasome within the inflammatory context of PD, via a transcription factor-miRNA regulatory pathway.